Ecopharmacovigilance and pharmacovigilance: an analysis of environment-related reporting in VigiBase

FormulationDE: an updated artificial intelligence system for drug-excipient compatibility prediction

US Food and Drug Administration Sentinel Initiative and Postmarket Drug Safety Surveillance

Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase

Oncofertility Pharmacovigilance in Women Receiving Immune Checkpoint Inhibitors: Reproductive Risks, Fertility Preservation, and Pregnancy Outcomes

Real-World Safety Profile of Levofloxacin: Pharmacovigilance Signals, Co-Medication Patterns, and Signal Validation

Precision and Personalized Medicine in Transdermal Drug Delivery Systems: Integrating AI Approaches

Hematological toxicities and thrombosis risk associated with immune checkpoint inhibitors: a pharmacovigilance study from 2014 to 2024

Active surveillance of drug safety in healthcare data: Sequential monitoring of bacterial and serious urinary tract infection risk in sodium-glucose cotransporter 2 inhibitor users

Age-Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

Global Pharmacovigilance of Aesthetic Botulinum Toxin Type A: Analysis of Adverse Event Reports From the USA, Europe, Canada, and Australia

A bibliometric analysis of the global research landscape on artificial intelligence applications in clinical medicine (2010–2025)

Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system

Strengthening pharmacovigilance through patient reporting: a scoping review of awareness, barriers, and facilitators

Safety of treatment regimens for drug-resistant TB over a 15-year period: a scoping review

A causal machine learning framework for pharmacovigilance signal detection in electronic health records: Drug-induced acute kidney injury

Serious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia

Too stressed to cope? A multiple mediation analysis of social bonds, sleep quality, and sleep disturbances in relation to prescription drug use among Chinese high school seniors

Pharmacists want action on fake weight-loss jabs

Pharmacovigilance Study of Drug-Related Renal Vascular Lesions Based on FAERS and Experimental Exploration

Real-world pharmacovigilance insights and clinical safety signal characterization of the classic mood stabilizer‑lithium carbonate: A disproportionality analysis based on FAERS data

AI-augmented pharmacovigilance for cardio-oncology: FDR- controlled disproportionality and anomaly detection of antineoplastic-associated cardiac events in FAERS (2015 Q1–2025 Q4)

Reproductive Toxicity of Rifampicin and Isoniazid on Male Reproductive System-A Review

Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes

Ensuring patient rights, safety, and welfare in “compassionate use” of drugs

The evolution of ethical and legal regulations of drug research

Barriers to Adverse Drug Reaction Reporting Among Physicians, Nurses, and Pharmacists: A Scoping Review Comparing High-Income Versus Low-/Middle-Income Countries

Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment

Pemphigoid associated with quinolone antibiotics: A real-world pharmacovigilance study of the FDA Adverse Event Reporting System and literature-based evidence

Patient Safety in Nuclear Medicine: Work Process Analysis From the SEIPS Model Perspective

Society for Maternal‐Fetal Medicine Special Statement: Assessment and management of reported penicillin allergy in pregnancy

Characterization of the Adverse Drug Reactions Associated with Psychotropic Medications Based on a Spontaneous Reporting Systems Database: A Retrospective Analysis

Early Evaluation of the Food and Drug Administration (FDA) Adverse Event Monitoring System (AEMS): An Analysis of Over 32 Million Pharmacovigilance Reports

Sex Differences in Psychotropic Drug Exposure and Safety: A Systematic Review Toward Personalized Dosing Strategies

Drug-induced fever: a pharmacovigilance analysis based on the FDA adverse event reporting system

ROLE OF TOXICOKINETICS IN IMPROVING DRUG SAFETY

Putting FAERS data into perspective: cautionary considerations for comparative safety assessment

Development of a European Union Time-Indexed Reference Dataset for Assessing the Performance of Signal Detection Methods in Pharmacovigilance using a Large Language Model

Drivers and strategies to combat substandard and falsified medicines in low-and middle-income countries: A systematic review of qualitative evidence

MHRA and eBay working in partnership to safeguard public health